Spero Therapeutics/ US84833T1034 /
14.06.2024 19:25:45 | Diff. -0,01 | Volumen | Geld- | Brief20:01:02 | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
1,35USD | -0,74% | 1.101 Umsatz: 1.470,35 |
-Geld Vol: - | 1,36Brief Vol: 900 | 1,36 | 1,32 |
GlobeNewswire
20:00
Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic ...
GlobeNewswire
19:54
ROSEN, LEADING INVESTOR COUNSEL, Encourages Axos Financial, Inc. Investors to Inquire About Securiti...
GlobeNewswire
19:41
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivota...
GlobeNewswire
19:40
Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18
GlobeNewswire
19:34
DOCS DEADLINE MONDAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Doximity, Inc. Investors to Secure Co...
GlobeNewswire
19:07
Weekly Report (June 7-13, 2024) Second Tranche of Stellantis 2024 Share Buyback Program
Newsfile Corp
19:04
Singapore Tourism Board and Yuewen Strike Strategic Collaboration, Yuewen CEO Hou Xiaonan: Integrate...
GlobeNewswire
19:01
Class Action Lawsuit Filed on Behalf of Charge Enterprises, Inc. (CRGE) Investors – Holzer & Holzer,...
GlobeNewswire
18:45
ROSEN, LEADING INVESTOR COUNSEL, Encourages Li Auto Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
18:35
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against 2U, Inc. – TWOU
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite